GENE ONLINE|News &
Opinion
Blog

Multiple Myeloma
Trials & Approvals Multiple Myeloma DrugArcellx
Clinical Hold Announced for Arcellx’s IMMagine-1 Phase 2 Clinical Program
2023-06-27
Special American Society of Hematology
64th ASH Annual Meeting and Exposition: Broad Coverage of Clinical, Social, and Nutritional Issues
2023-01-04
Partnerships CAR T-cell Therapy
Kite And Arcellx Join Forces for Developing Cell Therapy targeting Multiple Myeloma
2022-12-12
Trials & Approvals Multiple Myeloma
Janssen Scores Another Multiple Myeloma FDA Approval with Tecvayli
2022-10-25
Trials & Approvals Multiple Myeloma
Johnson & Johnson’s Multiple Myeloma Treatment Wins Accelerated Approval
2022-08-24
Trials & Approvals Multiple Myeloma
Oncopeptides’ Pepaxti Won EMA Approval for Multiple Myeloma
2022-08-19
Trials & Approvals Multiple Myeloma
Multiple Myeloma Treatment From BMS Proves Superior Life Expectancy After Further Trial
2022-08-10
Trials & Approvals Cell Therapy
J&J, Legend’s Cell Therapy Gets FDA Nod
2022-03-01
Trials & Approvals
Cartesian’s Off-the-shelf RNA Therapy for Myeloma Enters Clinical Trials
2022-01-27
Trials & Approvals Bristol Myers Squibb
Bristol-Myers Squibb’s Abecma Becomes First Approved CAR T-Cell Therapy for Multiple Myeloma in Japan
2022-01-24
China Multiple MyelomaChina NMPA
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
Trials & Approvals CAR T-cell Therapy
Considering Manufacturing and Commercial Advantages, Poseida Makes Strategic Shift Towards Allogeneic CAR-T Products
2021-11-10
M&A Multiple Myeloma
AbbVie to Acquire TeneoOne and Its Lead Multiple Myeloma Drug
2021-06-27
Trials & Approvals
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
Trials & Approvals CD38
Spotlight: Cancer Drug Licensed from Danish Antibody Developer Continues to Reap Benefits for Janssen
2020-09-04
1 2
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top